Dr. Moncef Slaoui, Trump's COVID vaccine czar, hopes that his aim and work to save American lives would not be disrupted by a transfer of power to Democrat Joe Biden. 

Biden was declared by major media organizations the winner of the presidential election. 

Slaoui oversees the Trump administration's COVID-19 vaccine program. He expressed concern that the administration's Operation Warp Speed would be interrupted by Biden's transition, according to a published report in CNBC. 

Slaoui told the news outlet that he hoped their work to fast track the development of the program will also not be interrupted. 

Slaoui also told the "Closing Bell" they are not going to be distracted by any circumstances or context like the transition of power. 

He added: "We will continue to run as fast as possible, as well as possible, always ensuring the safety and effectiveness of the vaccines. And clearly, we hope that there will be no disruption because of the transition."

Slaoui made the statement following the promising results of Pfizer's and Moderna's late-stage human clinical trials. He also made the remarks as a response to Biden's comments on Monday. 

Biden said "more people may die" if the Trump administration will continue to delay the transition of power. He also noted the importance of vaccine distribution. 

Biden's supposed upcoming term will start on Jan. 20, and if the vaccines will be available in the coming months, it is still within the time of President Donald Trump. 

The Trump administration has already spent billions of dollars to make sure that millions of Americans will get vaccinated. 

Meanwhile, Trump has yet to initiate the formal transition of power. Until this time, his camp continues to fight through various legal battles related to the election. It can be remembered that Trump earlier criticized voting by mail, claiming it can lead to widespread fraud. 

Slaoui spent decades at British pharmaceutical giant GlaxoSmithKline. Trump appointed him last May to oversee the Operation Warp Speed that aims to speed up the development, manufacturing, and distribution of coronavirus vaccines.

The program has already distributed billions of dollars to drug makers to help them accelerate the vaccine's development and distribution once it receives the emergency use authorization from health regulators like the U.S. Food and Drug Administration (FDA).

Slaoui emphasized that the administration's complex mission to save lives has never changed.

The COVID vaccine czar noted that "since day one our objective has been to go fast. And absolutely every day and every hour counts, and that's why we are where we are. Our focus is to save American lives, and people's life in general, and that's what we will continue focusing on."

The U.S. government has already spent over $2 billion on the American biotechnology firm Moderna. The company announced on Monday that its vaccine is nearly 95 percent effective in giving protection against COVID-19.